IGC Pharma Inc (IGC) Stock: Do Analysts Think You Should Hold?

Wall Street is positive on IGC Pharma Inc (IGC). On average, analysts give the stock a Buy rating. The average price target is $2.75, which means analysts expect the stock to rise by 663.89% over the next twelve months. That average ranking earns the stock an Analyst Rating of 36, which is better than 36% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating IGC a Buy today. Find out what this means to you and get the rest of the rankings on IGC!

See Full IGC Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With IGC Pharma Inc Stock Today?

IGC Pharma Inc (IGC) stock is up 5.35% while the S&P 500 has fallen -0.04% as of 1:01 PM on Friday, Mar 22. IGC has gained $0.02 from the previous closing price of $0.34 on volume of 856,525 shares. Over the past year the S&P 500 is higher by 32.68% while IGC has gained 5.88%. IGC lost -$0.25 per share the over the last 12 months. Click Here to get the full Stock Report for IGC Pharma Inc stock.